A quantitative assay for angiogenesis of cultured choroidal tissues in streptozotocin-diabetic Wistar and spontaneously diabetic GK rats

Japanese Journal of Pharmacology

Volumn 78, Issue 4, 1998, Pages 471-478

  Kobayashi, Shinjiro ^a   Fukuta, Mizuki ^a   Kontani, Hitoshi ^a   Yanagita, Sumino ^b   Kimura, Ikuko ^b  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Choroidal angiogenesis; Diabetic GK rat; In vitro assay for angiogenesis; Streptozotocin diabetic rat

Indexed keywords

GROWTH FACTOR; STREPTOZOCIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FETAL CALF SERUM; MALE; NONHUMAN; QUANTITATIVE ASSAY; RAT; STREPTOZOCIN DIABETES; TISSUE CULTURE;

EID: 0032421379     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.471     Document Type: Article

References (37)

1. Kornerup T: Studies in diabetic retinopathy: an investigation of 1,000 cases of diabetes. Acta Med Scand 153, 81-101 (1955)
2. Krolewski AS, Warram JH, Rand LI and Kahn CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317, 1390-1398 (1987)
3. Merimee TJ: Diabetic retinopathy. A synthesis of perspectives. N Engl J Med 322, 978-983 (1990)
4. Bernstein MH and Hollenberg MJ: Fine structure of the choriocapillaris and retinal capillaries. Invest Ophthalmol 4, 1016-1025 (1965)
5. Hidayat AA and Fine BS: Diabetic choroidopathy. Light and electron microscopic observation of seven cases. Ophthalmology 92, 512-522 (1985)
6. Fryczkowski AW, Hodes BL and Walker J: Diabetic choroidal and iris vasculature scanning electron microscopy finding. Int Ophthalmol 13, 269-279 (1989)
7. Goto Y, Kakizaki M and Masaki, N: Spontaneous diabetes produced by selective breeding of normal Wistar rat. Proc Jpn Acad 51, 80-85 (1975)
8. 2α-responses is inhibited by lipoxygenase- but not cyclooxygenase-inhibitors in mesenteric veins and arteries of mouse and rat. Jpn J Pharmacol 64, 65-70 (1994)
9. Ikeda H, Odaka H, Matsuo T, Suzuki K, Toyoda T and Goto Y: Diabetogenicity of sucrose in GK rats. In Lessons from Animal Diabetes, Edited by Goto Y and Kanazawa Y, pp 17-22, Smith-Gordon, London (1991)
10. Yagihashi S, Goto Y, Kakizaki M and Kaseda N: Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 15, 309-312 (1978)
11. Kimura I, Nakano Y, Naitoh T, Okabe M and Kimura M: Diabetic GK rat plasma but not normal Wistar rat plasma induces insulin-stimulated DNA synthesis in primary cultured smooth muscle cells in GK rat aorta. Jpn J Pharmacol 64, 195-200 (1994)
12. Kobayashi S, Kimura I and Kimura M: Diabetic state-modified macrophages in GK rat release platelet-derived growth factor-BB for tube formation of endothelial cells in rat aorta. Immunopharmacology 35, 171-180 (1996)
13. Kobayashi S, Okabe M, Kimura I and Kimura M: Interferon-γ-activated macrophages release interleukin-1α to increase tube formation from endothelial cells of rat aorta. Immunopharmacology 31, 93-101 (1995)
14. Kobayashi S, Luo, B, Okabe M, Kimura I and Kimura M: The diabetic state increases the activity but not the number of peritoneal macrophages in the GK rat promoting the tube formation of cultured endothelial cells in rat aorta. Biol Pharm Bull 19, 199-202 (1996)
15. Nicosia RF and Ottinetti A: Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63, 115-122 (1990)
16. Folkman J and Klagsbrun M: Angiogenic factors. Science 235, 442-447 (1987)
17. Lutty GA, McLeod DS, Merges C, Diggs A and Plouet J: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114, 971-977 (1996)
18. Bar RS: Vascular endothelium and diabetes mellitus. In Endothelial Cell Dysfunctions, Edited by Simionescu N and Simionescu M, pp 363-381, Plenum Press, New York (1992)
19. Schultz GS and Grant MB: Neovascular growth factors. Eye 5, 170-180 (1991)
20. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC and Gospondarowics D: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325, 257-259 (1987)
21. Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M, Hayashi H and Glaser BM: Correlation of fibrosis and transforming growth factor beta type 2 levels in the eye. J Clin Invest 83, 1661-1666 (1989)
22. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844 (1993)
23. King GL, Shiba T, Oliver J, Inoguchi T and Bursell S-E: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 45, 179-188 (1994)
24. Greene DA, Lattimer SA and Sima AA: Sorbitol, phosphoinositides, and sodium-potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med 316, 559-606 (1987)
25. Brownlee M, Cerami A and Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med 318, 1315-1321 (1988)
26. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW and Lyons TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91, 2470-2478 (1993)
27. +. Kidney Int 41, 778-788 (1992)
28. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C and Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813 (1993)
29. King GL, Johnson S and Wu G: Possible growth modulators involved in the pathogenesis of diabetic proliferative retinopathy. In Growth factors in Health and Disease, Edited by Westermark B, Betsholts C and Hokfelt B, pp 303-317, Elsevier Science, Amsterdam (1990)
30. Craven PA, Davidson CM and DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39, 667-674 (1990)
31. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W and King GL: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89, 11059-11063 (1992)
32. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15, 1835-1843 (1992)
33. Vlassara H, Bucala R and Striker L: Biology of disease. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 70, 138-151 (1994)
34. Schmidt AM, Hori O, Brett J, Yan SD, Wautier J-L and Stern D: Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14, 1521-1528 (1994)
35. Chappey O, Dosquet C, Wautier M-P and Wautier J-L: Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27, 97-108 (1997)
36. Antonelli-Orlidge A, Smith S and D'Amore P: An activated form of transforming growth factor-β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86, 4544-4548 (1989)
37. Hirota C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H and Kondo M: Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Müller cells. Biochem Biophys Res Commun 236, 712-715 (1997)